Usó Marco, Marta(Universitat Politècnica de València, 2015-06-05)
[EN] Lung cancer is the leading cause of cancer-related death worldwide, and is the third most common cancer type; it can be classified into two subgroups based on histology: non-small-cell lung cancer (NSCLC) and small-cell ...
[EN] The prognosis of non-small cell lung cancer (NSCLC) remains poor and heterogeneous and new biomarkers are needed. As the immune system plays a pivotal role in cancer, the study of immune-related markers may provide ...
Usó Marco, Marta(Universitat Politècnica de València, 2011-09-08)
Las células T reguladoras juegan un papel esencial en la tolerancia a las células tumorales. Moléculas
como CD4, CD8A, CD127, CTLA-4, IL-10, TGFB-1 y FOXP3 se han identificado como marcadores de
estas células. El objetivo ...
[EN] Background: The average five-year survival for non-small cell lung cancer (NSCLC) patients is approximately 15%. Emerging evidence indicates that microRNAs (miRNAs) constitute a new class of gene regulators in humans ...